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SI Text
Conventional expression of the M2–GIRK1/GIRK4 system with
both RGS4 and GoA produced consistent and accurate wild-
type dose–response relationships. We next proceeded to evalu-
ate the nonsense suppression protocols by using the wild-type
recovery experiment, in which a stop codon was placed at a
specific site within the M2 receptor gene, and THG73 tRNA
ligated with the wild-type amino acid was injected into the cell
to reestablish the wild-type protein. In these nonsense suppres-
sion experiments, we injected GoA and RGS4 mRNA, along
with the GIRK1/GIRK4 and mutant M2 receptor mRNA.
Analysis of the nonsense suppression data revealed a significant
increase in EC50 for W7.40Trp (440 nM) compared with the
conventional wild-type experiment (240 nM). In addition, there
was considerable variability among different batches of Xenopus
oocytes.
To remedy the failed wild-type recovery experiment and,
hopefully, the batch-to-batch data variability, we began to search
for trends between individual cell data and other properties of
our M2/GIRK1/GIRK4 signaling system. In our normal EC50
measurements, the responses to each drug dose are averaged
across all cells, and these averaged responses are fit to the Hill
equation. For individual cell analyses, we used the measurement
cEC50 to refer to the EC50 obtained when each cell’s dose–
response relationship data were individually fit to the Hill.
When we analyzed the relationship between IK,Agonist and
cEC50, we found that the nonsense suppression and conventional
expression cEC50 datasets diverged only when comparing cells
with low IK,Agonist (Fig. S1). By separating cells from both
conventional and W7.40Trp experiments into 2-A bins, we
showed that in the lowest-current bin (0–2 A), cells from our
nonsense suppression experiments had significantly higher
cEC50 values on average than cells in the conventional expression
experiments (conventional, 380 nM; nonsense suppression, 680
nM; t test P  0.001). If cells with IK,Agonist less than 2 A were
removed from both datasets, the difference between the 2 EC50
values narrowed (230 nM and 300 nM for the conventional and
nonsense suppression experiments, respectively). We concluded
that low levels of M2 receptor expression in the nonsense
suppression experiments—the source of low IK,Agonist levels—
produced abnormally shifted ACh dose–response relationships.
One possible explanation for this connection between expres-
sion levels and dose–response relationships is the injection of
GoA mRNA. Nonsense suppression produces lower levels of
receptor expression than conventional expression methods, and
this would produce a lower flux of free G subunits in response
to ACh application. Injection of GoA mRNA increases the level
of free G inside the cell, which could bind not only to the
endogenous Xenopus oocyte G subunits (the desired out-
come), but also to G subunits liberated by activation of the
GPCR. This would prematurely terminate M2–GIRK signaling.
Under such conditions, a higher dose of ACh would be needed
in low-expressing cells to produce the equivalent degree of signal
saturation compared with normally expressing cells. Such a
phenomenon would shift the dose–response relationship to
higher cEC50 values.
To test this hypothesis, we performed a series of wild-type
recovery experiments in which we reduced the amount of GoA
mRNA injected and monitored the change in mean cEC50. Cells
with 0 ng of injected GoA mRNA had cEC50s that were not
significantly different from the conventional expression exper-
iments (suppressed, 260  30 nM; conventional, 380  40 nM;
t test P  0.1) and were significantly lower than cells with 2 ng
(680  60 nM; t test P  0.002) or 1 ng (530  120 nM; t test
P  0.02) of GoA. When all of the cells from each condition
were pooled together, the EC50 for W7.40Trp without GoA was
290 nM, similar to the conventional wild-type EC50 of 240 nM.
As further confirmation of our hypothesis, we observed that
GoA injection does not change the dose–response relationship
of the conventionally expressedM2 receptor: the EC50 measured in
the conventional expression experiment with GoA was 250 nm,
whereas the EC50 recorded without the G protein was 240 nM.
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Fig. S1. Suppression M2AChR experiments exhibit higher cEC50 values in cells with low IK,Agonist. When IK,Agonist is plotted with cEC50, conventional and
suppressed wild-type data diverge most for cells with IK,Agonist 2 A.
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Fig. S2. Alignment of2AR, M2AChR, and D2DR binding-site sequences. Residues within 5 Å of the ligand in the2AR crystal structure are underlined. Aromatic
residues examined in this study are highlighted. We have adopted the numbering system, in which the most highly conserved residue of transmembrane helix
X is designated X.50. A residue 5 to the N terminus would be X.45; 5 to the C terminus would be X.55. Note that the X.50 residue does not necessarily lie in the
middle of the transmembrane helix; it is simply the most conserved residue [see: Ballesteros JA, Shi L, Javitch JA (2001) Mol Pharmacol 60:1–19].
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Table S1. Data for M2 AChR at W7.40, W6.48, and W3.28 and for the D2 receptor at F3.28, F5.47, W6.48, F6.51, and F6.52*
EC50 nH† n
M2 AChR
WT
W3.28
dCA 1,900  80 0.8  0.02 12
W6.48
Trp 310  6 0.8  0.01 17
F2Trp 1,100  70 0.8  0.04 12
F3Trp 420  30 1.1  0.06 14
W7.40
Trp 190  20 0.9  0.1 41
F1Trp 240  9 0.9  0.03 26
F2Trp 1,000  80 0.8  0.04 20
F3Trp 170  10 0.9  0.05 12
D2 receptor
WT 59  3 1.06  0.02 44
F3.28
Phe (WT) 55  1 1.13  0.04 5
F1Phe 140  10 0.84  0.03 4
F2Phe 36  1 1.0  0.1 3
F3Phe 140  10 0.89  0.14 3
Cha 97  2 1.03  0.04 5
F5.47
Cha 78  1 1.30  0.14 7
W6.48
Trp (WT) 42  4 0.96  0.05 15
F1Trp 120  10 0.98  0.05 14
F2Trp 290  30 0.95  0.06 11
F3Trp 840  60 0.85  0.05 13
F4Trp 1,800  300 0.84  0.06 16
Nap 190  20 1.12  0.06 8
F6.51
Phe (WT) 65  4 1.03  0.04 6
F1Phe 76  6 0.98  0.03 12
F2Phe 4,200  350 0.97  0.04 7
F3Phe 6,200  400 0.095  0.03 18
Cha 55,000  4,000 0.87  0.06 4
4-CNPhe 1340  160 0.94  0.06 4
4-MePhe 690  40 1.01  0.02 6
3,5-Me2Phe 75,000  5000 0.89  0.05 6
F6.52
Phe (WT) 45  3 1.04  0.11 6
F1Phe 41  2 1.01  0.11 7
F2Phe 1,700  100 1.14  0.03 8
F3Phe 5,500  400 1.09  0.03 7
4-CNPhe 240  30 1.06  0.05 5
4-BrPhe 1,500  100 1.02  0.04 4
4-MePhe 91  6 1.00  0.05 5
3,5-Me2Phe 33,000  3,000 1.11  0.10 7
Conventional
T7.39V 100  20 0.89  0.12 4
D3.32E 50,000  4000 1.07  0.08 9
D3.32N 140,000  10,000 1.12  0.03 6
D3.32S 730,000  60,000 1.13  0.09 5
D3.32A 2,000,000  300,000 0.83  0.07 2
*EC50 (nM) and nH values are  SEM.
†Hill coefficient.
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